BellRing Brands (BRBR)
(Delayed Data from NYSE)
$57.76 USD
-0.60 (-1.03%)
Updated May 28, 2024 04:00 PM ET
After-Market: $57.76 0.00 (0.00%) 7:58 PM ET
1-Strong Buy of 5 1
C Value D Growth B Momentum D VGM
BellRing Brands (BRBR) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$64.53 | $70.00 | $50.00 | 10.57% |
Price Target
Based on short-term price targets offered by 15 analysts, the average price target for BellRing Brands comes to $64.53. The forecasts range from a low of $50.00 to a high of $70.00. The average price target represents an increase of 10.57% from the last closing price of $58.36.
Analyst Price Targets (15)
Broker Rating
BellRing Brands currently has an average brokerage recommendation (ABR) of 1.47 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 16 brokerage firms. The current ABR compares to an ABR of 1.50 a month ago based on 15 recommendations.
Of the 16 recommendations deriving the current ABR, 11 are Strong Buy and two are Buy. Strong Buy and Buy respectively account for 68.75% and 12.5% of all recommendations. A month ago, Strong Buy made up 66.67%, while Buy represented 13.33%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 11 | 11 | 10 | 10 | 10 |
Buy | 2 | 2 | 2 | 2 | 2 |
Hold | 3 | 3 | 3 | 3 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.47 | 1.47 | 1.50 | 1.50 | 1.50 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
5/8/2024 | Mizuho SecuritiesUSA | John J Baumgartner | Strong Buy | Strong Buy |
5/8/2024 | Evercore Partners | David Palmer | Strong Buy | Strong Buy |
5/7/2024 | William Blair | Jon R Andersen | Strong Buy | Strong Buy |
5/7/2024 | Stephens | Jim Salera | Hold | Hold |
5/7/2024 | Needham & Company | Matthew R Mcginley | Moderate Buy | Moderate Buy |
1/3/2024 | Truist Securities | William B Chappell | Strong Buy | Hold |
12/12/2023 | D.A. Davidson | Brian Holland | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.47 |
ABR (Last week) | 1.47 |
# of Recs in ABR | 16 |
Average Target Price | $64.53 |
LT Growth Rate | 19.70% |
Industry | Medical - Products |
Industry Rank by ABR | 89 of 252 |
Current Quarter EPS Est: | 0.44 |